Stocks rise over Pfizer’s Covid vaccine

THE rally in global equities extended Tuesday, a day after Pfizer said its late-stage trial of its Covid-19 vaccine had shown promising results, but caution over the depth of the coronavirus pandemic and an uncertain US political climate limited gain. Futures tied to the Dow Jones Industrial Average, the S&P 500, and the Nasdaq rose…

Subscribe to read full article. Subscribe today

Related posts

JSE to tighten algo-trading, market-access rules

Gold jumps as prospects of Iran deal temper inflation concerns

African leaders call for regional cooperation, market reforms to unlock nuclear energy financing

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Read More